Vis enkel innførsel

dc.contributor.authorAndenæs, Randi
dc.contributor.authorHelseth, Sølvi
dc.contributor.authorMisvær, Nina
dc.contributor.authorRibu, Lis
dc.date.accessioned2016-11-11T10:16:08Z
dc.date.accessioned2017-04-06T11:55:46Z
dc.date.available2016-11-11T10:16:08Z
dc.date.available2017-04-06T11:55:46Z
dc.date.issued2016-10-19
dc.identifier.citationJournal of Multidisciplinary Healthcare 2016, 9:547-555language
dc.identifier.issn1178-2390
dc.identifier.urihttps://hdl.handle.net/10642/4706
dc.description.abstractObjective: The aim of this study was to examine how neuroticism, stressful life events, self- rated health, life satisfaction, and selected lifestyle factors were related to insomnia both by sex and among users and nonusers of prescribed sleep medication (PSM). Design: Cross-sectional data from the Norwegian Nord-Trøndelag Health Study (HUNT3, 2006–2008), a population-based health survey, were linked to individual data from the Norwe- gian Prescription Database. Methods: Logistic regression analyses were used to investigate the associations between the selected variables and insomnia in both males and females and among subjects using and not using PSM. Individuals were considered to have a presumptive diagnosis of insomnia disorder if they reported difficulty with sleep initiation, sleep maintenance, or early morning awakening several days per week for the last 3 months. PSMs were categorized as anxiolytics or hypnotics; the dose was estimated according to defined daily dose (DDD). Results: Of the total 50,805 participants, 6,701 (13.2%) used PSM. The proportions of PSM users were larger among elderly participants. Increased risk of insomnia was strongly associated with poor self-rated health and higher level of neuroticism. These associations were evident for both sexes and were similar among both users and nonusers of PSM. Low satisfaction with life was strongly related to insomnia, but only among nonusers of PSM. Increased doses of PSM were not associated with reduced likelihood of insomnia. Conclusion: Insomnia is a problem among both users and nonusers of PSM and is associated with psychosocial factors. Our findings suggest that successful treatment for sleep problems should take individual variation into account, such as age, sex, personality traits, satisfaction with life, and health perception.language
dc.language.isoenlanguage
dc.publisherDove Medical Presslanguage
dc.rights© 2016 Andenæs et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)language
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0
dc.subjectPrescription sleep medicationlanguage
dc.subjectHypnoticslanguage
dc.subjectAnxiolyticslanguage
dc.subjectInsomnialanguage
dc.subjectLife satisfactionlanguage
dc.subjectSelf-rated healthlanguage
dc.subjectNeuroticismlanguage
dc.subjectSexlanguage
dc.subjectHUNTlanguage
dc.titlePsychosocial factors are strongly associated with insomnia in users and nonusers of prescribed sleep medication: evidence from the HUNT3 study.language
dc.typePeer reviewedlanguage
dc.typeJournal article
dc.date.updated2016-11-11T10:16:08Z
dc.description.versionpublishedVersionlanguage
dc.identifier.doihttp://dx.doi.org/10.2147/JMDH.S116462
dc.identifier.cristin1399481


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

© 2016 Andenæs et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work 
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For 
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)
Med mindre annet er angitt, så er denne innførselen lisensiert som © 2016 Andenæs et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)